Use of dietary supplements and medication among postmenopausal women with vasomotor symptoms

References

• Nelson HD. Menopause. Lancet 2008;371:760–770
   PubMed Web of Science ®Google Scholar
• MacLennan A, Broadbent J, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Systematic Reviews 2004;Issue 4.
   PubMedGoogle Scholar
• Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333
   PubMed Web of Science ®Google Scholar
• Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–427
   PubMed Web of Science ®Google Scholar
• Bakken K, Alsaker E, Eggen AE, Lund E. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. Int J Cancer 2004;112:130–134
   PubMed Web of Science ®Google Scholar
• Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47–53
   PubMed Web of Science ®Google Scholar
• Watson J, Wise L, Green J. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 2007;63:843–849
   PubMed Web of Science ®Google Scholar
• Waaseth M, Bakken K, Lund E. Patterns of hormone therapy use in the Norwegian Women and Cancer study (NOWAC) 1996–2005. Maturitas 2009;63:220–226
   PubMed Web of Science ®Google Scholar
• Jacobsen S, Harg P. Hormonbehandling av kvinner med menopausale symptomer [Hormonal treatment of women with symptoms of menopause]. Nytt om legemidler 2003;26:3–4
   Google Scholar
• Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11–33
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805–813
   PubMed Web of Science ®Google Scholar
• Borud E, Alraek T, White A, Fonnebo V, Grimsgaard S. The effect of TCM acupuncture on hot flushes among menopausal women (ACUFLASH) study: A study protocol of an ongoing multi-centre randomised controlled clinical trial. BMC Complement Alternat Med 2007;7:6
   PubMedGoogle Scholar
• Borud EK, Alraek T, White A, et al The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial. Menopause 2009;16:484–493
   PubMed Web of Science ®Google Scholar
• Lund E, Kumle M, Braaten T, et al External validity in a population-based national prospective study – the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control 2003;14:1001–1008
   PubMed Web of Science ®Google Scholar
• ICH Harmonized Tripartite Guideline for Good Clinical Practice, available from: http://www.ich.org/LOB/media/MEDIA482.pdf. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use,1996;E6(R1):59 pp
   Google Scholar
• Lund E, Dumeaux V, Braaten T, et al Cohort profile: the Norwegian Women and Cancer Study – NOWAC – Kvinner og kreft. Int J Epidemiol 2008;37:36–41
   PubMed Web of Science ®Google Scholar
• Waaseth M, Bakken K, Dumeaux V, et al Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis. BMC Women's Health 2008;8:1
   PubMedGoogle Scholar
• Brustad M, Braaten T, Lund E Predictors for cod-liver oil supplement use – the Norwegian Women and Cancer Study. Eur J Clin Nutr 2004;58:128–136
   PubMed Web of Science ®Google Scholar
• The WHO Collaborating Centre for Drug Statistics Methodology. Oslo: Norwegian Institute of Public Health; [updated 2009-02-26; cited March 2008]; Available from http://www.whocc.no/atcddd/
   Google Scholar
• Rønning M, ed. Drug Consumption in Norway 1998–2002, Oslo: Norwegian Institute of Public Health, 2003
   Google Scholar
• Borud EK, Martinussen M, Eggen AE, Grimsgaard S. The Women's Health Questionnaire (WHQ): A psychometric evaluation of the 36-item Norwegian version. Scand J Psychol 2009;50:183–189
   PubMed Web of Science ®Google Scholar
• Dahle EJ, Lydersen S, Moen MH. Bruk av østrogen og alternativ behandling blant norske kvinner 50–69 år [Use of hormone replacement therapy and alternative therapies among Norwegian women aged 50–69]. Tidsskr Nor Laegeforen 2006;126:318–320
   PubMedGoogle Scholar
• Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2008 March 13 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar